Arkolith/Insider Trading/DSGN/Form 4

Schmid John P.

DirectorDesign Therapeutics, Inc. (DSGN) · full profile →Form 4 · filed Mar 25, 2024
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2024Buy(P)18K$3.74$67K27K
Mar 22, 2024Buy(P)9K$3.62$33K9K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-009063) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML